2023:

Manso JA, Carabias A, Sárkány Z, de Pereda JM, Pereira PJB, Macedo-Ribeiro S. (2023) "Pathogen-specific structural features of Candida albicans Ras1 activation complex: uncovering new antifungal drug targets." mBio 14(4):e0063823. [PubMed] [doi: 10.1128/mbio.00638-23]
Also available in bioRxiv. 2022.08.23.504951. [doi: 10.1101/2022.08.23.504951]

Rodríguez-Blázquez A, Carabias A, Morán-Vaquero A, de Cima S, Luque-Ortega JR, Alfonso C, Schuck P, Manso JA, Macedo-Ribeiro S, Guerrero C, de Pereda JM (2023) "Crk proteins activate the Rap1 guanine nucleotide exchange factor C3G by segregated adaptor-dependent and -independent mechanisms." Cell Commun Signal 21(1):30. [PubMed] [doi: 10.1186/s12964-023-01042-2 ]
Also available in bioRxiv. 2022.11.24.515150. [doi: 10.1101/2022.11.24.515150 ]

Stam W, Wachholz GE, de Pereda JM, Kapur R, van der Schoot E, Margadant C (2023) "Fetal and neonatal alloimmune thrombocytopenia: Current pathophysiological insights and perspectives for future diagnostics and treatment." Blood Rev. 59:101038. [PubMed] [doi: 10.1016/j.blre.2022.101038]

2022:

Hernández-Cano L, Fernández-Infante C, Herranz Ó, Berrocal P, Lozano FS, Sánchez-Martín MA, Porras A, Guerrero C (2022) "New functions of C3G in platelet biology: Contribution to ischemia-induced angiogenesis, tumor metastasis and TPO clearance". Front. Cell Dev. Biol. 10:1026287. [PubMed] [doi: 10.3389/fcell.2022.1026287]

Palao N, Sequera C, Cuesta áM, Baquero C, Bragado P, Gutierrez-Uzquiza A, Sánchez A, Guerrero C, Porras A (2022) "C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process". Int. J. Biol. Sci. 18(15):5873-5884. [PubMed] [doi: 10.7150/ijbs.73192]

Manso JA, Marcos T, Ruiz-Martín V, Casas J, Alcón P, Sánchez Crespo M, Bayón Y, de Pereda JM, Alonso A. (2022) "PSTPIP1-LYP phosphatase interaction: structural basis and implications for autoinflammatory disorders." Cell. Mol. Life Sci. 79, 131. [PubMed] [doi: 10.1007/s00018-022-04173-w]

2021:

Te Molder L, de Pereda JM*, Sonnenberg A* (2021) "Regulation of hemidesmosome dynamics and cell signaling by integrin α6β4." J Cell Sci 134(18):jcs259004. [PubMed] [doi: 10.1242/jcs.259004]

Te Molder L, Kreft M, Heemskerk N, Schuring J, de Pereda JM, Wilhelmsen K, Sonnenberg A (2021) "EGFR-dependent tyrosine phosphorylation of integrin β4 is not required for downstream signaling events in cancer cell lines." Scientific Reports 11(1):8675. [PubMed] [doi: 10.1038/s41598-021-88134-6 ]

Marín-Quílez A, García-Tuñón I, Fernández-Infante C, Hernández-Cano L, Palma-Barqueros V, Vuelta E, Sánchez-Martín M, González-Porras JR, Guerrero C, Benito R, Rivera J, Hernández-Rivas JM, Bastida JM (2021) "Characterization of the Platelet Phenotype Caused by a Germline RUNX1 Variant in a CRISPR/Cas9-Generated Murine Model." Thromb Haemost. in press. [doi: 10.1055/s-0041-1723987]

Carabias A, Guerrero C, de Pereda JM (2021) "C3G self-regulatory mechanism revealed: implications for hematopoietic malignancies." Mol Cell Oncol. 8(1):1837581. [PubMed] [doi: 10.1080/23723556.2020.1837581]

Manzano S, Gutierrez-Uzquiza A, Bragado P, Cuesta AM, Guerrero C, Porras A (2021) "C3G Protein, a New Player in Glioblastoma". Int. J. Mol. Sci. 22(18):10018. [PubMed] [doi: 10.3390/ijms221810018.]

Porras A, Sequera C, Bragado P, Gutiérrez-Uzquiza A and Guerrero C (2021) "Contribution of C3G and other GEFs to liver cancer development and progression". Hepatoma Res. 7:40. [doi: 10.20517/2394-5079.2021.16.]

Manzano S, Gutierrez-Uzquiza A, Bragado P, Sequera C, Herranz Ó, Rodrigo-Faus M, Jauregui P, Morgner S, Rubio I, Guerrero C, Porras A (2021) "C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells". Cell Death Dis. 12(4):348. [PubMed] [doi: 10.1038/s41419-021-03631-w.]

2020:

Carabias A, Gómez-Hernández M, de Cima S, Rodríguez-Blázquez A, Morán-Vaquero A, González-Sáenz P, Guerrero C, de Pereda JM (2020) "Mechanisms of autoregulation of C3G, activator of the GTPase Rap1, and its catalytic deregulation in lymphomas." Science Signaling 13(647):eabb7075. [PubMed] [doi: 10.1126/scisignal.abb7075]

Sequera C, Bragado P, Manzano S, Arechederra M, Richelme S, Gutiérrez-Uzquiza A, Sánchez A, Maina F, Guerrero C, Porras A (2020) "C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation." Cancers 12(8):E2282. [PubMed] [doi: 10.3390/cancers12082282]

Gutiérrez-Herrero S, Fernández-Infante C, Hernández-Cano L, Ortiz-Rivero S, Guijas C, Martín-Granado V, González-Porras JR, Balsinde J, Porras A, Guerrero C (2020) "C3G contributes to platelet activation and aggregation by regulating major signaling pathways." Signal Transduct Target Ther 5:29. [PubMed] [doi: 10.1038/s41392-020-0119-9]

Blanco-Antona F, González-Sarmiento R, García-Cenador B, Lozano FS (2020) "Transdermal buprenorphine for controlling pain in patients with critical lower-limb ischemia." Pain Med. 21(5):1083-1085. [PubMed] [doi: 10.1093/pm/pnz165 ]

Lozano Sánchez FS, Rubio Taboada C, González Porras JR (2020) "Venous thrombosis associated with venous compression syndromes." Med Clin (Barc). 154(10):406-411. [PubMed] [doi: 10.1016/j.medcli.2019.12.004 ]

Lozano FS, García-Alonso J, Torres JA, Velasco L, Salvador R, Peña R, González-Porras JR (2020) "Decision-making and therapeutic options in intact splenic artery aneurysms: single-center experience and literature review." Int Angiol. 154(10):406-411. [PubMed] [doi: 10.23736/S0392-9590.20.04304-7 ]

Díaz-Casado E, Gómez-Nieto R, de Pereda JM, Muñoz LJ, Jara-Acevedo M, López DE (2020) "Analysis of gene variants in the GASH/Sal model of epilepsy." PLoS One 15(3):e0229953. [PubMed] [doi: 10.1371/journal.pone.0229953]

Usategui-Martín R, Gestoso-Uzal N, Calero-Paniagua I, De Pereda JM, Del Pino-Montes J, González-Sarmiento R. (2020) "A mutation in p62 protein (p. R321C), associated to Paget's disease of bone, causes a blockade of autophagy and an activation of NF-kB pathway." Bone 133:115265. [PubMed] [doi: 10.1016/j.bone.2020.115265]

2019:

Manso JA, Gómez-Hernández M, Carabias A, Alonso-García N, García-Rubio I, Kreft M, Sonnenberg A, de Pereda JM (2019) "Integrin α6β4 recognition of a linear motif of bullous pemphigoid antigen BP230 controls its recruitment to hemidesmosomes." Structure 27, 952-964. [PubMed] [doi: 10.1016/j.str.2019.03.016]
Also available in BioRxiv [doi: 10.1101/402123] and in Cell Press Sneak Peek [doi: 10.2139/ssrn.3330561].

Giordano G, Remo A, Porras A, Pancione M. (2019) "Immune Resistance and EGFR Antagonists in Colorectal Cancer." Cancers (Basel). 11(8):1089. [PubMed] [doi: 10.3390/cancers11081089]

Giordano G, Parcesepe P, Rosario D’Andrea M, Coppola L, Di Raimo T, Remo A, Manfrin E, Fiorini C, Scarpa A, Amoreo CA, Conciatori F, Milella M, Caruso FP, Cerulo L, Porras A and Pancione M. (2019) "JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer." J Exp Clin Cancer Res.. 38(1):28. [PubMed] [doi: 10.1186/s13046-018-1019-5]

Vicente-Vicente L, González-Calle D, Casanova AG, Hernández-Sánchez MT, Prieto M, Rama-Merchán JC, Martín-Moreiras J, Martín-Herrero F, Sánchez PL, López-Hernández FJ, Cruz-González I, Morales AI (2019) "Quercetin, a Promising Clinical Candidate for The Prevention of Contrast-Induced Nephropathy." Int J Mol Sci. 20(19):4961. [PubMed] [doi: 10.3390/ijms20194961 ]

2018:

Ortiz-Rivero S, Baquero C, Hernández-Cano L, Roldán-Etcheverry JJ, Gutiérrez-Herrero S, Fernández-Infante C, Martín-Granado V, Anguita E, de Pereda JM, Porras A, Guerrero C (2018) "C3G, through its GEF activity, induces megakaryocytic differentiation and proplatelet formation." Cell Commun. Signal.. 16(1):101. [PubMed] [doi: 10.1186/s12964-018-0311-5]

Manso JA, Gómez-Hernández M, Carabias A, Alonso-García N, García-Rubio I, Kreft M, Sonnenberg A, de Pereda JM (2018) "Integrin α6β4 recognition of a linear motif of bullous pemphigoid antigen BP230 controls its recruitment to hemidesmosomes." BioRxiv. [doi: 10.1101/402123]

Buey RM, Fernández-Justel D, de Pereda JM, Revuelta JL, Schürmann P, Buchanan BB, Balsera M. (2018) "Ferredoxin-linked flavoenzyme defines a family of pyridine nucleotide-independent thioredoxin reductases." PNAS 115(51):12967-12972. [PubMed] [doi: 10.1073/pnas.1812781115]

Bastida JM, Lozano ML, Benito R, Janusz K, Palma-Barqueros V, Del Rey M, Hernández-Sánchez JM, Riesco S, Bermejo N, González-García H, Rodriguez-Alén A, Aguilar C, Sevivas T, López-Fernández MF, Marneth AE, van der Reijden BA, Morgan NV, Watson SP, Vicente V, Hernández-Rivas JM, Rivera J, González-Porras JR. (2018) "Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders." Haematologica. 103(1):148-162. [PubMed] [doi: 10.3324/haematol.2017.171132]

Sequera C, Vázquez-Carballo A, Arechederra M, Fernández-Veledo S, Porras A. (2018) "TWEAK promotes migration and invasion in MEFs through a mechanism dependent on ERKs activation and Fibulin 3 down-regulation." J Cell Physiol. 233(2):968-978. [PubMed] [doi: 10.1002/jcp.25942]

Martin-Rufino JD, Lozano FS, Redondo AM, Villaron EM, Rueda R, Fernandez-Samos R, Sanchez-Guijo F (2018) "Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease)." Stem Cell Res Therl. 9(1):150. [PubMed] [doi: 110.1186/s13287-018-0901-6 ]

2017:

Martín-Granado V, Ortiz-Rivero S, Carmona R, Gutiérrez-Herrero S, Barrera M, San Segundo L, Sequera C, Perdiguero P, Lozano F, Martín-Herrero F, González-Porras JR, Muñoz-Chápuli R, Porras A. and Guerrero, C. (2017) "C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis." Oncotarget 8(67): 110994-111011. [PubMed] [doi: 10.18632/oncotarget.22339]

Buey RM, Arellano JB, López-Maury L, Galindo-Trigo S, Velázquez-Campoy A, Revuelta JL, de Pereda JM, Florencio FJ, Schürmann P, Buchanan BB, Balsera M (2017) "Unprecedented pathway of reducing equivalents in a diflavin-linked disulfide oxidoreductase." PNAS 114(48): 12725-12730. [PubMed] [doi: 10.1073/pnas.1713698114]

Bastida JM, Cano-Mozo MT, López-Cadenas F, Vallejo VE, Merchán S, Santos-Montón C, González-Calle D, Carrillo J, Martín AA, Torres-Hernández JA, González M, Martín-Herrero F, Pabón P, González-Porras JR (2017) "Hemorrhagic pericardial effusion as the debut of acquired hemophilia in a chronic lymphocytic leukemia patient: A case report, and a review of acquired hemophilia A-related hematological malignancies." Medicine (Baltimore) 96(47): e8669. [PubMed] [doi: 10.1097/MD.0000000000008669]

Alegre O, Formiga F, López-Palop R, Marín F, Vidán MT, Martínez-Sellés M, Carol A, Sionis A, Díez-Villanueva P, Aboal J, Palau-Vendrel A, Bueno H, Rivera AP, Sanchís J, Abu-Assi E, Corbí M, Castillo JC, Bañeras J, González-Salvado V, Cequier À, Ariza-Solé A; Martín- Herrero F(LONGEVO-SCA registry investigators). (2017) "An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes." J Am Med Dir Assoc pii: S1525-8610(17)30581-9. [PubMed] [doi: 10.1016/j.jamda.2017.10.007]

Bastida JM, Benito R, Janusz K, Díez-Campelo M, Hernández-Sánchez JM, Marcellini S, Girós M, Rivera J, Lozano ML, Hortal A, Hernández-Rivas JM, González-Porras JR. (2017) "Two novel variants of the ABCG5 gene cause xanthelasmas and macrothrombocytopenia: a brief review of hematologic abnormalities of sitosterolemia." J Thromb Haemost 15(9):1859-1866. [PubMed] [doi: 10.1111/jth.13777]

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Pérez-Rus G, Hernández-Rivas JA, Bernat S, Bastida JM, Martínez-Badas MP, Martínez-Robles V, Soto I, Olivera P, Bolaños E, Alonso R, Entrena L, Gómez-Nuñez M, Alonso A, Yera Cobo M, Caparrós I, Tenorio M, Arrieta-Cerdán E, Lopez-Ansoar E, García-Frade J, González-Porras JR (2017) "Use of eltrombopag for secondary immune thrombocytopenia in clinical practice." Br J Haematol 178(6):959-970. [PubMed] [doi: 10.1111/bjh.14788]

Ramos TL, Sánchez-Abarca LI, Rosón-Burgo B, Redondo A, Rico A, Preciado S, Ortega R, Rodríguez C, Muntión S, Hernández-Hernández á, De Las Rivas J, González M, González-Porras JR, Del Cañizo C, Sánchez-Guijo F (2017) "Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis." PLoS One 12(8):e0182470. [PubMed] [doi: 10.1371/journal.pone.0182470]

Sevivas T, Bastida JM, Paul DS, Caparros E, Palma-Barqueros V, Coucelo M, Marques D, Ferrer-Marín F, González-Porras JR, Vicente V, Hernández-Rivas JM, Watson SP, Lozano ML, Bergmeier W, Rivera J. (2017) "Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis." Platelets 29(2):192-195. [PubMed] [doi: 10.1080/09537104.2017.1336214]

Gonzalez-Porras JR, Lopez-Cadenas F, Alberca I, Bastida JM. (2017) "Top-level sport in athletes with severe haemophilia A." Haemophilia 23(4):e391-e393. [PubMed] [doi: 10.1111/hae.13283]

Buey RM, Fernández-Justel D, Marcos-Alcalde I, Winter G, Gómez-Puertas P, de Pereda JM, Luis Revuelta J (2017) "A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases." Sci Rep 7(1):2648. [PubMed] [doi: 10.1038/s41598-017-02805-x]

Ruiz MA, González-Porras JR, Aranguren JL, Franco E, Villasante F, Tuñón J, González-López TJ, de Salas-Cansado M, Soto J. (2017) "Development and validation of a new questionnaire measuring treatment satisfaction in patients with non-valvular atrial fibrillation: SAFUCA." Qual Life Res 26(3):767-778. [PubMed] [doi: 10.1007/s11136-016-1474-4]

Vicente V, Martín A, Lecumberri R, Coll-Vinent B, Suero C, González-Porras JR, Marco P, Mateo J, Roldán V, Soulard S, Crespo C, Camats M; Grupo DECOVER (2017) "Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal." Emergencias 29(1):18-26. [PubMed]

Bastida JM, González-Porras JR, Jiménez C, Benito R, Ordoñez GR, álvarez-Román MT, Fontecha ME, Janusz K, Castillo D, Fisac RM, García-Frade LJ, Aguilar C, Martínez MP, Bermejo N, Herrero S, Balanzategui A, Martin-Antorán JM, Ramos R, Cebeiro MJ, Pardal E, Aguilera C, Pérez-Gutierrez B, Prieto M, Riesco S, Mendoza MC, Benito A, Hortal Benito-Sendin A, Jiménez-Yuste V, Hernández-Rivas JM, García-Sanz R, González-Díaz M, Sarasquete ME. (2017) "Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes." Thromb Haemost 117(1):66-74. [PubMed] [doi: 10.1160/TH16-05-0375]

Buey RM, Galindo-Trigo S, López-Maury L, Velázquez-Campoy A, Revuelta JL, Florencio FJ, de Pereda JM, Schürmann P, Buchanan BB, Balsera M (2017) "A New Member Of The Thioredoxin Reductase Family From Early Oxygenic Photosynthetic Organisms." Mol Plant 10(1):212-215. [PubMed] [doi: 10.1016/j.molp.2016.06.019]

García-Tuñón I, Hernández-Sánchez M, Ordoñez JL, Alonso-Pérez V, Quijada M, Benito R, Guerrero C, Hernández-Rivas J and Sánchez-Martín M (2017) "The CRISPR-CAS9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leucemia." Oncotarget 8:26027-26040. [PubMed] [doi: 10.18632/oncotarget.15215]

Balikov DA, Brady SK, Ko UH, Shin JH, de Pereda JM, Sonnenberg A, Sung H-J, & Lang MJ (2017) "The nesprin-cytoskeleton interface probed directly on single nuclei is a mechanically rich system." Nucleus 8(5):534-547. [PubMed] [doi: 10.1080/19491034.2017.1322237]

2016:

Martínez-Martínez I, González-Porras JR, Cebeira MJ, de Arriba F, Espín S, Bohdan N, Corrales FJ, Corral J, Vicente V. (2016) "Identification of a new potential mechanism responsible for severe bleeding in myeloma: immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant." Haematologica 101(10):e423-e426. [PubMed] [doi: 10.3324/haematol.2016.144873]

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Jarque I, Pérez-Rus G, Pérez-Crespo S, Bernat S, Hernández-Rivas JA, Andrade MM, Cortés M, Gómez-Nuñez M, Olivera P, Martínez-Robles V, Fernández-Rodríguez A, Fuertes-Palacio MA, Fernández-Miñano C, de Cabo E, Fisac R, Aguilar C, Bárez A, Peñarrubia MJ, García-Frade LJ, González-Porras JR (2016) "Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice." Eur J Haematol 97(3):297-302. [PubMed] [doi: 10.1111/ejh.12725]

Blanco F, Muriel C, Labrador J, Gonzalez-Porras JR, Gonzalez-Sarmiento R, Lozano FS (2016) "Influence of UGT2B7, CYP3A4, and OPRM1 Gene Polymorphisms on Transdermal Buprenorphine Pain Control in Patients with Critical Lower Limb Ischemia Awaiting Revascularization." Pain Pract 16(7):842-9. [PubMed] [doi: 10.1111/papr.12343]

Ortega E, Manso JA, Buey RM, Carballido AM, Carabias A, Sonnenberg A, de Pereda JM (2016) "The Structure of the Plakin Domain of Plectin Reveals an Extended Rod-like Shape." J Biol Chem 291(36), 18643-18662. [PubMed] [doi:10.1074/jbc.M116.732909]

Manso JA, García-Rubio I, Gómez-Hernández M, Ortega E, Buey RM, Carballido AM, Carabias A, Alonso-García N, de Pereda JM (2016) "Purification and Structural Analysis of Plectin and BPAG1e." Methods Enzymol 569:177-196. [PubMed] [doi:10.1016/bs.mie.2015.05.002]

Bastida JM, Del Rey M, Lozano ML, Sarasquete ME, Benito R, Fontecha ME, Fisac R, García-Frade LJ, Aguilar C, Martínez MP, Pardal E, Aguilera C, Pérez B, Ramos R, Cardesa MR, Martin-Antorán JM, Silvestre LA, Cebeira MJ, Bermejo N, Riesco S, Mendoza MC, García-Sanz R, González-Díaz M, Hernández-Rivas JM, González-Porras JR (2016) "Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders." Haemophilia 22(4):590-7. [PubMed] [doi: 10.1111/hae.12908]

Priego N, Arechederra M, Sequera C, Vázquez A, Gutiérrez-Uzquiza A, Martín-Granado V, Ventura JJ, Kazanietz M, Guerrero C and Porras A (2016) "C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38a activation, while it impairs tumor growth through p38a-independent mechanisms." Oncotarget 7:45060-45078. [PubMed] [doi: 10.18632/oncotarget.9911]

Allende M, Molina E, Guruceaga E, Tamayo I, González-Porras JR, Gonzalez-López TJ, Toledo E, Rabal O, Ugarte A, Roldán V, Rivera J, Oyarzabal J, Montes R, Hermida J. (2016) "Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk." Cardiovasc Res 110(3):309-18. [PubMed] [doi: 10.1093/cvr/cvw049]

Lozano ML, Revilla N, Gonzalez-Lopez TJ, Novelli S, González-Porras JR, Sánchez-Gonzalez B, Bermejo N, Pérez S, Lucas FJ, álvarez MT, Arilla MJ, Perera M, do Nascimento J, Campos RM, Casado LF, Vicente V. (2016) "Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines." Ann Hematol 95(7):1089-98. [PubMed] [doi: 10.1007/s00277-016-2665-3]

Labrador J, González-Rivero J, Monroy R, Lozano FS, López-Corral L, Caballero MD, Bastida JM, González-Porras JR. (2016) "Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center." Thromb Res 142:52-6. [PubMed] [doi: 10.1016/j.thromres.2016.02.016]

Allende M, Molina E, González-Porras JR, Toledo E, Lecumberri R, Hermida J (2016) "Short Leukocyte Telomere Length Is Associated With Cardioembolic Stroke Risk in Patients With Atrial Fibrillation." Stroke 47(3):863-5. [PubMed] [doi: 10.1161/STROKEAHA.115.011837]

2015:

Lozano FS, Sánchez-Fernández J, González-Porras JR, García-Alovio J, Santos JA, Mateos R, Alberca I. (2015) "Slow femoral venous flow and venous thromboembolism following inguinal hernioplasty in patients without or with low molecular weight heparin prophylaxis." Hernia 19(6):901-8. [PubMed] [doi:10.1007/s10029-015-1353-x]

Buey RM, Ledesma-Amaro R, Velazquez-Campoy A, Balsera M, Chagoyen M, de Pereda JM, Revuelta JL (2015) "Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases." Nat Commun 6,8923. [PubMed] [doi:10.1038/ncomms9923]

Buey RM, Ledesma-Amaro R, Balsera M, de Pereda JM, Revuelta JL (2015) "Increased riboflavin production by manipulation of inosine 5'-monophosphate dehydrogenase in Ashbya gossypii." Appl Microbiol Biotechnol 99(22):9577-9589. [PubMed] [doi:10.1007/s00253-015-6710-2]

Suárez-Causado A, Caballero-Díaz D, Bertrán E, Roncero C, Addante A, García-álvaro M, Fernández M, Herrera B, Porras A, Fabregat I, Sánchez A. (2015) "HGF/c-Met signaling promotes liver progenitor cell migration and invasion by an epithelialmesenchymal transition-independent, phosphatidyl inositol-3 kinase-dependent pathway in an in vitro model." Biochim Biophys Acta 1853(10 Pt A):2453-63. [PubMed] [doi:10.1016/j.bbamcr.2015.05.017]

Bastida JM, Cabrero M, Lopez-Godino O, Lopez-Parra M, Sanchez-Guijo F, Lopez-Corral L, Vazquez L, Caballero D, Del Cañizo C (2015) "Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome." Leuk Res 39(8):828-34. [PubMed] [doi:10.1016/j.leukres.2015.05.003]

Ketema M, Secades P, Kreft M, Nahidiazar L, Janssen H, Jalink K, de Pereda JM, Sonnenberg A (2015) "The rod domain is not essential for the function of plectin in maintaining tissue integrity." Mol Biol Cell 26(13):2402-2417. [PubMed] [doi:10.1091/mbc.E15-01-0043]

San Roman JA, Sánchez PL, Villa A, Sanz-Ruiz R, Fernandez-Santos ME, Gimeno F, Ramos B, Arnold R, Serrador A, Gutiérrez H, Martin-Herrero F, Rollán MJ, Fernández-Vázquez F, López-Messa J, Ancillo P, Pérez-Ojeda G, Fernández-Avilés F. (2015) "Comparison of Different Bone Marrow-Derived Stem Cell Approaches in Reperfused STEMI. A Multicenter, Prospective, Randomized, Open-Labeled TECAM Trial." J Am Coll Cardiol 65(22):2372-82. [PubMed] [doi:10.1016/j.jacc.2015.03.563]

Labrador J, López-Corral L, Vázquez L, Sánchez-Guijo FM, Guerrero C, Sánchez-Barba M, Lozano FS, Alberca I, del Cañizo MC, Caballero MD and González-Porras JR. (2015) "Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant." Br J Haematol 169:719-725. [PubMed] [doi:10.1111/bjh.13344]

Alonso-García N, García-Rubio I, Manso JA, Buey RM, Urien H, Sonnenberg A, Jeschke G de Pereda JM, (2015) "Combination of X-ray crystallography, SAXS and DEER to obtain the structure of the FnIII-3,4 domains of integrin α6β4." Acta Cryst D 71(4):969-985. [PubMed] [doi:10.1107/S1399004715002485]

González-Porras JR, Mingot-Castellano ME, Andrade MM, Alonso R, Caparrós I, Arratibel MC, Fernández-Fuertes F, Cortti MJ, Pascual C, Sánchez-González B, Bernat S, Fuertes-Palacio MA, Vázquez-Paganini JA, Olivera PE, Alvarez-Román MT, Jarque I, Cortés M, Martínez-Robles V, Díaz-Gálvez FJ, Calbacho M, Fernández-Miñano C, Garcia-Frade J, González-López TJ. (2015) "Use of eltrombopag after romiplostim in primary immune thrombocytopenia." Br J Haematol 169(1):111-116. [PubMed] [doi:10.1111/bjh.13266]

González-López TJ, Pascual C, álvarez-Román MT, Fernández-Fuertes F, Sánchez-González B, Caparrós I, Jarque I, Mingot-Castellano ME, Hernández-Rivas JA, Martín-Salces M, Solán L, Beneit P, Jiménez R, Bernat S, Andrade MM, Cortés M, Cortti MJ, Pérez-Crespo S, Gómez-Núñez M, Olivera PE, Pérez-Rus G, Martínez-Robles V, Alonso R, Fernández-Rodríguez A, Arratibel MC, Perera M, Fernández-Miñano C, Fuertes-Palacio MA, Vázquez-Paganini JA, Gutierrez-Jomarrón I, Valcarce I, de Cabo E, Sainz A, Fisac R, Aguilar C, Paz Martínez-Badas M, Peñarrubia MJ, Calbacho M, de Cos C, González-Silva M, Coria E, Alonso A, Casaus A, Luaña A, Galán P, Fernández-Canal C, Garcia-Frade J, González-Porras JR. (2015) "Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia." Am J Hematol 90(3):E40-3. [PubMed] [doi:10.1002/ajh.23900]

Barrabés JA, Bardají A, Jiménez-Candil J, del Nogal Sáez F, Bodí V, Basterra N, Marco E, Melgares R, Cuñat de la Hoz J, Fernández-Ortiz A. Martín-Herrero F(investigators of DIOCLES study). (2015) "Prognosis and management of acute coronary syndrome in Spain in 2012: the DIOCLES study." Rev Esp Cardiol (Engl Ed) 68(2):98-106. [PubMed] [doi:10.1016/j.rec.2014.03.010]

Arechederra M, Priego N, Vázquez-Carballo A, Sequera C, Cerezo-Guisado MI, Roncero C, Ortiz S, Cuenda A, Guerrero C and Porras A (2015) "p38MAPK down-regulate fibulin 3 expression through methylation of gene regulatory sequences. Role on migration and invasion." J Biol Chem 290:4383-4397. [PubMed] [doi:10.1074/jbc.M114.582239]

Trujillo-Santos J, Lozano F, Lorente MA, Adarraga D, Hirmerova J, Del Toro J, Mazzolai L, Barillari G, Barrón M, Monreal M; RIETE Investigators (2015) "A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs." Am J Med 128(1):90.e9-15. [PubMed] [doi:10.1016/j.amjmed.2014.08.023]

Sánchez-Sánchez B, Gutiérrez-Herrero S, López-Ruano G, Prieto-Bermejo R, Romo-González M, Llanillo M, Pandiella A, Guerrero C, San Miguel J.F, Sánchez-Guijo F, del Cañizo C and Hernández-Hernández A (2015) "NADPH oxidases as therapeutic targets in chronic myeloid leukaemia." Clinical Cancer Research 20:4014-4025. [PubMed] [doi:10.1158/1078-0432.CCR-13-3044]

2013:

Labrador J, Lopez-Anglada L, Perez-Lopez E, Lozano FS, Lopez-Corral L, Sanchez-Guijo FM, Vazquez L, Perez Rivera JA, Martin-Herrero F, Sanchez-Barba M, Guerrero C, del Cañizo MC, Caballero MD, San Miguel JF, Alberca I and Gonzalez-Porras JR (2013) "Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients." Haematologica 98(3):437-443. [PubMed] [doi:10.3324/haematol.2012.069559]

Maia V, Ortiz-Rivero S, Sanz M, Gutierrez-Berzal J, Alvarez-Fernández I, Gutierrez-Herrero S, de Pereda JM, Porras A, Guerrero C (2013) "C3G forms complexes with Bcr-Abl and p38alpha MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion." Cell Commun Signal 11(1):9. [PubMed] [doi:10.1186/1478-811X-11-9]

Sammito M, Millán C, Rodríguez DD, de Ilarduya IM, Meindl K, De Marino I, Petrillo G, Buey RM, de Pereda JM, Zeth K, Sheldrick GM, Usón I (2013) "Exploiting tertiary structure through local folds for crystallographic phasing." Nat Methods 10(11):1099-1101. [PubMed] [doi:10.1038/nmeth.2644]

de la Puerta ML, Trinidad AG, Rodríguez MdC, de Pereda JM, Sánchez Crespo M, Bayón Y, Alonso A (2013) "The Autoimmunity Risk Variant LYP-W620 Cooperates with CSK in the Regulation of TCR Signaling." Plos ONE 8(1): e54569. [PubMed] [doi:10.1371/journal.pone.0054569]

2012:

Gutierrez-Herrero S, Maia V, Gutierrez-Berzal J, Calzada N, Sanz M, Gonzalez-Manchon C, Pericacho M, Ortiz-Rivero S, Gonzalez-Porras JR, Arechederra M, Porras A and Guerrero, C (2012) "C3G transgenic mice models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity." BBA Mol. Cell. Res. 1823:1366-1377. [PubMed] [doi:10.1016/j.bbamcr.2012.05.021]

Cordoba I, Pegenaute C, Gonzalez-Lopez TJ, Martin-Herrero F, Guerrero C, Cabrero M, Garcia-Sanchez MH, Lozano FS, Alberca I and Gonzalez-Porras JR (2012) "Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation." Eur. J. Hematol. 89:250-255. [PubMed] [doi:10.1111/j.1600-0609.2012.01809.x]